PERIOPERATIVE MEDICINE / LETTER TO EDITOR
 
TOPICS
REFERENCES (8)
1.
Farrugia FA, Charalampopoulos A. Pheochromocytoma. Endocr Regul 2019; 53: 191-212. DOI: 10.2478/enr-2019-0020.
 
2.
Kazic MR, Zivaljevic VR, Milan ZB, Paunovic IR. Perioperative risk factors, morbidity, and outcome of 145 patients during phaeochromocytoma resection. Acta Chir Belg 2011; 111: 223-227.
 
3.
Kamath AS, Singh K. Perioperative Management of Pheochromocytoma. [Updated 2023 Jul 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. Available from: https://www.ncbi.nlm.nih.gov/b....
 
4.
Lenders JWM, Kerstens MN, Amar L, Prejbisz A, Robledo M, Taieb D, et al. Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J Hypertens 2020; 38: 1443-1456. DOI: 10.1097/HJH.0000000000002438.
 
5.
Groeben H, Nottebaum BJ, Alesina PF, Traut A, Neumann HP, Walz MK. Perioperative α-receptor blockade in phaeochromocytoma surgery: an observational case series. Br J Anaesth 2017; 118: 182-189. DOI: 10.1093/bja/aew392.
 
6.
Bihain F, Nomine-Criqui C, Guerci P, Gasman S, Klein M, Brunaud L. Management of patients with treatment of pheochromocytoma: a critical appraisal. Cancers (Basel) 2022; 14: 3845. DOI: 10.3390/cancers14163845.
 
7.
Buscemi S, Di Buono G, D’Andrea R, Ricci C, Alberici L, Querci L, et al. Perioperative management of pheochromocytoma: from a dogmatic to a tailored approach. J Clin Med 2021; 10: 3759. DOI: 10.3390/jcm10163759.
 
8.
Kulkarni S, Glover M, Kapil V, Abrams SML, Partridge S, McCormack T, et al. Management of hypertensive crisis: British and Irish Hypertension Society Position document. J Hum Hypertens 2023; 37: 863-879. DOI: 10.1038/s41371-022-00776-9.
 
eISSN:1731-2531
ISSN:1642-5758
Journals System - logo
Scroll to top